8-K
filed January 14, 2025, 6:59 PM ET
CIK 0000316253
regulatory
confidence high
sentiment negative
materiality 0.80
ENZO BIOCHEM INC: Nasdaq/NYSE listing notice — Enzo Biochem receives NYSE non-compliance notices for low market cap & stock price
ENZO BIOCHEM INC
- NYSE notified Enzo of non-compliance due to 30-day avg market cap <$50M and equity <$50M (Oct 31, 2024).
- Additionally, average closing price of ENZ common stock was <$1.00 over consecutive 30 trading days.
- Company has 18 months to cure market cap/equity deficiency and 6 months to cure price deficiency.
- Enzo will notify NYSE by Jan 23, 2025 and submit a compliance plan by Feb 21, 2025.
- Common stock continues to trade on NYSE subject to other listing standards.
Key facts
Extracted from this filing and checked against the source text.
Listing & Compliance Notices
SEC 8-K Item 3.01
confidence 0.9
ENZO BIOCHEM INC received a nyse deficiency notice notice regarding market value (rules 802.01B).
- Exchange
- nyse
- Notice
- deficiency notice
- Deficiency
- market value
- Rules
- 802.01B
Exact text from the filing
January 8, 2025 Enzo Biochem, Inc. (the “Company”) received a letter from the New York Stock Exchange (the “NYSE”) notifying the Company that it is not in compliance with (i) Section 802.01B of the NYSE Listed Company Ma
View on SEC.gov
Listing & Compliance Notices
SEC 8-K Item 3.01
confidence 0.9
ENZO BIOCHEM INC received a nyse deficiency notice notice regarding minimum bid price (rules 802.01C).
- Exchange
- nyse
- Notice
- deficiency notice
- Deficiency
- minimum bid price
- Rules
- 802.01C
Exact text from the filing
January 8, 2025 Enzo Biochem, Inc. (the “Company”) received a letter from the New York Stock Exchange (the “NYSE”) notifying the Company that it is not in compliance with (i) Section 802.01B of the NYSE Listed Company Ma
View on SEC.gov
Listing & Compliance Notices
SEC 8-K Item 3.01
confidence 0.95
ENZO BIOCHEM INC received a nyse noncompliance notice notice regarding market value (rules 802.01B, 802.01C).
- Exchange
- nyse
- Notice
- noncompliance notice
- Deficiency
- market value
- Rules
- 802.01B, 802.01C
Exact text from the filing
January 8, 2025 Enzo Biochem, Inc. (the “Company”) received a letter from the New York Stock Exchange (the “NYSE”) notifying the Company that it is not in compliance with (i) Section 802.01B of the NYSE Listed Company Manual because as of January 7, 2025, the Company’s 30 trading-day average market capitalization was less than $50 million and its last reported stockholder’s equity as of October 31, 2024 was less than $50 million and (ii) Section 802.01C of the NYSE Listed Company Manual because the average closing price of the Company’s Common Stock (the “Common Stock”) was less than $1.00 ove
View on SEC.gov
Listing & Compliance Notices
SEC 8-K Item 3.01
confidence 0.95
ENZO BIOCHEM INC received a nyse noncompliance notice notice regarding minimum bid price (rules 802.01B, 802.01C).
- Exchange
- nyse
- Notice
- noncompliance notice
- Deficiency
- minimum bid price
- Rules
- 802.01B, 802.01C
Exact text from the filing
January 8, 2025 Enzo Biochem, Inc. (the “Company”) received a letter from the New York Stock Exchange (the “NYSE”) notifying the Company that it is not in compliance with (i) Section 802.01B of the NYSE Listed Company Manual because as of January 7, 2025, the Company’s 30 trading-day average market capitalization was less than $50 million and its last reported stockholder’s equity as of October 31, 2024 was less than $50 million and (ii) Section 802.01C of the NYSE Listed Company Manual because the average closing price of the Company’s Common Stock (the “Common Stock”) was less than $1.00 ove
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.